[go: up one dir, main page]

AR007695A1 - Procedimiento para preparar fenilheterociclos utiles como inhibidores de cox-2 - Google Patents

Procedimiento para preparar fenilheterociclos utiles como inhibidores de cox-2

Info

Publication number
AR007695A1
AR007695A1 ARP970102940A ARP970102940A AR007695A1 AR 007695 A1 AR007695 A1 AR 007695A1 AR P970102940 A ARP970102940 A AR P970102940A AR P970102940 A ARP970102940 A AR P970102940A AR 007695 A1 AR007695 A1 AR 007695A1
Authority
AR
Argentina
Prior art keywords
formula
compound
reacting
give
cox
Prior art date
Application number
ARP970102940A
Other languages
English (en)
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of AR007695A1 publication Critical patent/AR007695A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Un procedimiento para preparar fenilheterociclos de fórmula I útiles en el tratamiento de la inflamación y otras enfermedades mediadas por ciclooxigenasa-2, de fórmula (I) en donde R2 es un grupo orgánico de reacción estable tal como fenilmono -o di-sustituido en donde el sustituyente se selecciona delgrupo que consiste de: (1) hidrógeno, (2) halógeno, (3) alcoxi C1-6 (4) tialquil C1-6, (5) CH, (6) CF3, y (7) alquil C1-6; R3 y R3 se seleccionan cadauno independientemente dehidróge no y alquil C1-4, que comprende: (b) hacer reaccionar tioanisol en un solvente inerte en presencia de cloruro de acetilo ycloruro de aluminio para dar un compuesto de fórmula 3; (b2) hacer reaccionar un compuesto de fórmula 3 en unsolvente ine rte en presencia de un catalizadorde transferencia de fase y un agente oxidante para dar un compuesto de fórmula 4.(b) hacer reaccionar un compuesto de fórmula 4 en ácido acético acuoso conbromo para dar un compuesto de fórmula 2 (b4)haciendo reacc ionar un compuesto de fórmula 2 en N,N-dimetilformamida con un derivado de ácido acético defórmula 6 en presencia de una base inorgánica para producir un compuesto de fórmula 5a, (b5) tratar el compuesto 5a en un solvente polaraprótico con unab ase orgánica para dar un compuesto de fórmula 1.
ARP970102940A 1996-07-03 1997-07-01 Procedimiento para preparar fenilheterociclos utiles como inhibidores de cox-2 AR007695A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2120096P 1996-07-03 1996-07-03
GBGB9615867.0A GB9615867D0 (en) 1996-07-03 1996-07-29 Process of preparing phenyl heterocycles useful as cox-2 inhibitors

Publications (1)

Publication Number Publication Date
AR007695A1 true AR007695A1 (es) 1999-11-10

Family

ID=26309770

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970102940A AR007695A1 (es) 1996-07-03 1997-07-01 Procedimiento para preparar fenilheterociclos utiles como inhibidores de cox-2

Country Status (25)

Country Link
US (1) US5840924A (es)
EP (1) EP0912537B1 (es)
JP (1) JP3071472B2 (es)
CN (1) CN1097046C (es)
AR (1) AR007695A1 (es)
AT (1) ATE266651T1 (es)
AU (1) AU717835B2 (es)
BR (1) BR9710099A (es)
CA (1) CA2258048C (es)
CZ (1) CZ297257B6 (es)
DE (1) DE69729096T2 (es)
DK (1) DK0912537T3 (es)
EA (1) EA001629B1 (es)
ES (1) ES2218691T3 (es)
GB (1) GB9615867D0 (es)
HR (1) HRP970351B1 (es)
HU (1) HU224840B1 (es)
NZ (1) NZ333379A (es)
PL (1) PL195025B1 (es)
PT (1) PT912537E (es)
RS (1) RS49591B (es)
SK (1) SK283997B6 (es)
TW (1) TW419474B (es)
UA (1) UA57029C2 (es)
WO (1) WO1998000416A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040072889A1 (en) * 1997-04-21 2004-04-15 Pharmacia Corporation Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
CA2322824A1 (en) * 1998-03-13 1999-09-16 Merck & Co., Inc. Combination therapy and composition for acute coronary ischemic syndrome and related conditions
US6031108A (en) * 1998-09-16 2000-02-29 Bayer Corporation Process for the preparation of 2-(methylsulfonyl)-5-(trifluoromethyl)-1,3,4-thiadiazole (TDA sulfone)
US6649645B1 (en) 1998-12-23 2003-11-18 Pharmacia Corporation Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
AU2001258677A1 (en) * 2000-05-22 2001-12-03 Dr. Reddy's Research Foundation Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them
DE10129320A1 (de) * 2001-06-19 2003-04-10 Norbert Mueller Verwendung von COX-2 Inhibitoren zur Behandlung von Schizophrenie, wahnhaften Störungen, affektiven Störungen oder Ticstörungen
US20060167074A1 (en) * 2001-06-19 2006-07-27 Norbert Muller Methods and compositions for the treatment of psychiatric disorders
WO2003030812A2 (en) * 2001-10-10 2003-04-17 Shasun Chemicals And Drugs Limited 1-[(4-methyl thio)phenyl]-2-(phenyl acetoxy)-1-ethanone and a process for preparing the same
WO2003059347A1 (en) * 2002-01-10 2003-07-24 Pharmacia & Upjohn Company Use of cox-2 inhibitors in combination with antiviral agents for the treatment of papilloma virus infections
TW200403072A (en) * 2002-01-23 2004-03-01 Upjohn Co Combination therapy for the treatment of bacterial infections
US20040147581A1 (en) * 2002-11-18 2004-07-29 Pharmacia Corporation Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy
US20040220155A1 (en) * 2003-03-28 2004-11-04 Pharmacia Corporation Method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith
WO2004098618A2 (en) * 2003-05-07 2004-11-18 Osteologix A/S Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions
ES2275218T3 (es) * 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
WO2005009342A2 (en) * 2003-07-16 2005-02-03 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
US20050119262A1 (en) * 2003-08-21 2005-06-02 Pharmacia Corporation Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent
WO2005023189A2 (en) * 2003-09-03 2005-03-17 Pharmacia Corporation Method of cox-2 selective inhibitor and nitric oxide-donating agent
EP1784179A4 (en) 2004-08-24 2010-03-31 Merck Sharp & Dohme COMBINATION THERAPY FOR THE TREATMENT OF CYCLOOXYGENASE-2-MEDIATED DISEASES OR CONDITIONS IN PATIENTS WITH RISK TO THROMBOTIC CARDIOVASCULAR EVENTS
AU2006244393B2 (en) * 2005-05-05 2012-06-21 Cook Biotech Incorporated Implantable materials and methods for inhibiting tissue adhesion formation
CN104774186A (zh) * 2015-04-28 2015-07-15 江苏中旗作物保护股份有限公司 农药除草剂异恶唑草酮的合成方法
US11096924B2 (en) 2016-09-07 2021-08-24 Trustees Of Tufts College Combination therapies using immuno-dash inhibitors and PGE2 antagonists
EP3883562A4 (en) 2018-11-21 2022-08-03 Tremeau Pharmaceuticals, Inc. PURIFIED FORMS OF ROFECOXIB AND METHODS OF MAKING AND USING
US10945992B1 (en) 2019-11-13 2021-03-16 Tremeau Pharmaceuticals, Inc. Dosage forms of rofecoxib and related methods
US11161833B1 (en) 2021-04-09 2021-11-02 Tremeau Pharmaceuticals, Inc. Deuterated etoricoxib, methods of manufacture, and use thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5916884A (ja) * 1982-07-19 1984-01-28 Fujisawa Pharmaceut Co Ltd 新規フラン化合物
US4968817A (en) * 1984-07-27 1990-11-06 National Distillers And Chemical Corporation Manufacture of gamma-crotonolactone by carbonylation of glycidol
DE3615157A1 (de) * 1986-05-05 1987-11-12 Schwabe Willmar Gmbh & Co 5-arylalkyl-4-alkoxy-2(5h)-furanone, zwischenprodukte und verfahren zu ihrer herstellung sowie ihre anwendung als therapeutische wirkstoffe
DE3718527A1 (de) * 1987-06-03 1988-12-15 Basf Ag Verfahren zur herstellung von 2(5h)-furanonen
DE4014420A1 (de) * 1989-09-23 1991-04-04 Bayer Ag 5h-furan-2-on-derivate
US5207817A (en) * 1989-09-23 1993-05-04 Bayer Aktiengesellschaft Herbicidal 5H-furan-2-one derivatives
AU7559691A (en) * 1990-04-17 1991-11-11 Allergan, Inc. 2(5h)-furanones substituted in the 5 and or in the 4 position, as anti-inflammatory agents
US5393150A (en) * 1991-09-05 1995-02-28 Fort; Chris Bifurcated keyboard arrangement
IT1254558B (it) * 1992-03-26 1995-09-25 Mini Ricerca Scient Tecnolog Composti a base di 3,4-diaril-(5h)-furan-2-one ad attivita' fungicida 3
CA2152792C (en) * 1993-01-15 2000-02-15 Stephen R. Bertenshaw Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
JPH09501920A (ja) * 1993-08-19 1997-02-25 ワーナー−ランバート・コンパニー 非ペプチドエンドセリンアンタゴニスト▲i▼
WO1995018799A1 (en) * 1994-01-10 1995-07-13 Merck Frosst Canada Inc. Phenyl heterocycles as cox-2 inhibitors
US5475995A (en) * 1994-05-16 1995-12-19 Livingston; George G. Truck spare tire locking rod

Also Published As

Publication number Publication date
HRP970351A2 (en) 1998-06-30
CN1097046C (zh) 2002-12-25
HRP970351B1 (en) 2003-02-28
CZ297257B6 (cs) 2006-10-11
GB9615867D0 (en) 1996-09-11
EA001629B1 (ru) 2001-06-25
CA2258048C (en) 2006-08-15
DK0912537T3 (da) 2004-08-30
SK283997B6 (sk) 2004-07-07
EP0912537B1 (en) 2004-05-12
YU59298A (sh) 2000-03-21
BR9710099A (pt) 1999-08-10
PL195025B1 (pl) 2007-08-31
CA2258048A1 (en) 1998-01-08
ATE266651T1 (de) 2004-05-15
UA57029C2 (uk) 2003-06-16
DE69729096D1 (de) 2004-06-17
RS49591B (sr) 2007-06-04
PT912537E (pt) 2004-08-31
WO1998000416A1 (en) 1998-01-08
CN1224422A (zh) 1999-07-28
EA199900079A1 (ru) 1999-06-24
HK1017355A1 (en) 1999-11-19
CZ436898A3 (cs) 1999-06-16
HUP9903836A2 (hu) 2001-05-28
EP0912537A1 (en) 1999-05-06
ES2218691T3 (es) 2004-11-16
DE69729096T2 (de) 2005-04-28
AU717835B2 (en) 2000-04-06
US5840924A (en) 1998-11-24
SK179398A3 (en) 2000-04-10
PL330750A1 (en) 1999-05-24
HUP9903836A3 (en) 2001-06-28
JPH11514002A (ja) 1999-11-30
HU224840B1 (en) 2006-03-28
TW419474B (en) 2001-01-21
AU3588697A (en) 1998-01-21
NZ333379A (en) 2000-09-29
JP3071472B2 (ja) 2000-07-31

Similar Documents

Publication Publication Date Title
AR007695A1 (es) Procedimiento para preparar fenilheterociclos utiles como inhibidores de cox-2
BRPI0212775B8 (pt) composto de 1,2,4-triazol e medicamento
PT1222173E (pt) Processo para a preparacao de um derivado de 4-trifluorometil-sulfinilpirazole
PE20091582A1 (es) Procedimiento para la preparacion de dihidropteridinonas
ES8503669A1 (es) Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos.
AR079237A2 (es) Proceso para la preparacion de derivados de dibenzo(b,f) azepina
Dai et al. Enantioselective oxidation of sulfides with H 2 O 2 catalyzed by a pre-formed manganese complex
ES8603497A1 (es) Procedimiento para preparar derivados de cefalosporina
ES2176719T3 (es) Derivados de benzopirano que tienen una accion antagonista de leucotrienos.
IS6449A (is) Aðferð til framleiðslu á 5-sýanóþalíði
ES8607960A1 (es) Procedimiento para preparar acidos aroil-benzofuran y benzo-tiofen-aceticos y-propionicos
Nishiguchi et al. Acid-catalyzed isomerization of 1-acyl-and 1-thioacylaziridines. I. Mechanism of nucleophilic substitution
Fugmann et al. Pigments from the Puffball Calvatia rubro‐flava− Isolation, Structural Elucidation and Synthesis
Li et al. One-pot multistep synthesis of 3-aminoindolizine derivatives
CO5190690A1 (es) Compuestos quimicos sustituidos, como inhibidores de cinasa deshidrogenasa de pi ruvato
ES8204410A1 (es) Procedimiento de obtencion de derivados de acido fenilaceti-co
ES8106516A1 (es) Procedimiento de preparacion de nuevos derivados halovinca- monas y de sus sales de adicion acidas farmaceuticamente aceptables e isomeros opticamente activos de los mismos
ES8703423A1 (es) Un procedimiento para producir un derivado de acido indola- cetico
AR003328A1 (es) Proceso para la preparacion de nitro-sustituido-difenileteres, utiles como herbicidas o como intermediarios en la sintesis de herbicidas
KR960702432A (ko) P-알킬- 및p-아릴설포닐벤조산 유도체의 제조방법(process to prepare p-alkyl-and p-arylsulphonylbenzoic acid derivatives)
CY1108861T1 (el) Μεθοδος δια την παρασκευη παραγωγων 4-(ιμιδαζολ-1-υλ)-βενζολοσουλφοναμιδης
ES8303333A1 (es) Procedimiento para preparar derivados de indol o de indolina.
AR043624A1 (es) Procedimiento para preparar 2-ciano-3-hidroxi-n- (fenil) but-2-enamidas
ATE90331T1 (de) Herstellung von derivaten der glutarsaeure.
ATE286048T1 (de) Verfahren zur herstellung von carbostyril- derivaten

Legal Events

Date Code Title Description
FG Grant, registration